Atrion Corporation (NASDAQ:ATRI) Files An 8-K Other EventsItem 8.01. Other Events.
Atrion Corporation (NASDAQ:ATRI) Files An 8-K Other Events
On March 14, 2017, Atrion Corporation (the “Company”) filed an Annual Report on Form 10-K/A for the year ended December 31, 2016 with the Securities and Exchange Commission that included an Explanatory Note reporting that on March 13, 2017 the Company’s filing agent had inadvertently, and prior to the issuance of the Report of the Independent Registered Public Accounting Firm, prior to the recommendation of the Audit Committee that the Company’s audited financial statements as of and for the year ended December 31, 2016 be included in the Annual Report on Form 10-K and prior to the approval of the Company’s Board of Directors, filed an Annual Report on Form 10-K for the year ended December 31, 2016 for the Company (the “Original Filing”). As stated in such Explanatory Note, our Annual Report on Form 10-K/A for the year ended December 31, 2016 replaces the Original Filing. Accordingly, the Original Filing should be disregarded in its entirety.
About Atrion Corporation (NASDAQ:ATRI)
Atrion Corporation (Atrion) is engaged in developing and manufacturing products, primarily for medical applications. The Company’s medical products range from fluid delivery devices to ophthalmic and cardiovascular products. Its fluid delivery products include valves that promote infection control and needle safety. It has developed a range of valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, intravenous, catheter and other applications in areas, such as anesthesia and oncology. Its cardiovascular product, MPS2 Myocardial Protection System (MPS2), is the system used in open-heart surgery that delivers fluids and medications, mixes critical drugs and controls temperature, pressure and other variables. Atrion is a manufacturer of specialized medical devices that disinfect contact lenses. Its other medical and non-medical product lines consist of instrumentation and associated disposables. Atrion Corporation (NASDAQ:ATRI) Recent Trading Information
Atrion Corporation (NASDAQ:ATRI) closed its last trading session up +4.50 at 469.60 with 12,762 shares trading hands.
Atrion Corporation (Atrion) is engaged in developing and manufacturing products, primarily for medical applications. The Company’s medical products range from fluid delivery devices to ophthalmic and cardiovascular products. Its fluid delivery products include valves that promote infection control and needle safety. It has developed a range of valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, intravenous, catheter and other applications in areas, such as anesthesia and oncology. Its cardiovascular product, MPS2 Myocardial Protection System (MPS2), is the system used in open-heart surgery that delivers fluids and medications, mixes critical drugs and controls temperature, pressure and other variables. Atrion is a manufacturer of specialized medical devices that disinfect contact lenses. Its other medical and non-medical product lines consist of instrumentation and associated disposables. Atrion Corporation (NASDAQ:ATRI) Recent Trading Information
Atrion Corporation (NASDAQ:ATRI) closed its last trading session up +4.50 at 469.60 with 12,762 shares trading hands.
